Discontinuation report RAN-GABAPENTIN
| Report ID | 80051 |
| Drug Identification Number | 02319071 |
| Brand name | RAN-GABAPENTIN |
| Common or Proper name | RAN-GABAPENTIN |
| Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | GABAPENTIN |
| Strength(s) | 400MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 & 500 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2018-12-04 |
| Remaining supply date | 2018-12-04 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | 300 mg remains available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2019-03-29 | French | Compare |
| v1 | 2019-03-29 | English | Compare |
Showing 1 to 2 of 2